Assessing Incyte: Insights From 11 Financial Analysts
Portfolio Pulse from Benzinga Insights
Incyte (NASDAQ:INCY) has been analyzed by 11 financial analysts, showing a range of opinions from bullish to bearish. The average 12-month price target has increased by 2.73% to $71.82. Analysts have adjusted their ratings and price targets, reflecting their views on Incyte's market performance. Despite a 9.34% revenue growth, Incyte faces challenges with a net margin of -42.6% and ROE of -10.6%.
October 01, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Incyte has received mixed analyst ratings, with a slight increase in the average price target. Despite revenue growth, the company faces profitability challenges, which may affect investor sentiment.
The analysis shows a mixed sentiment among analysts, with some raising and others lowering their ratings. The increase in the average price target suggests a slightly positive outlook, but the company's financial challenges, such as low net margin and ROE, may offset this. The overall impact on the stock price is likely neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100